Amalgamated Bank’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Hold |
1,354
| – | – | ﹤0.01% | 2326 |
|
|
2025
Q1 | $8K | Buy |
1,354
+264
| +24% | +$1.56K | ﹤0.01% | 2481 |
|
|
2024
Q4 | $9K | Hold |
1,090
| – | – | ﹤0.01% | 2491 |
|
|
2024
Q3 | $20K | Hold |
1,090
| – | – | ﹤0.01% | 2141 |
|
|
2024
Q2 | $11K | Hold |
1,090
| – | – | ﹤0.01% | 2401 |
|
|
2024
Q1 | $12K | Sell |
1,090
-1,734
| -61% | -$19.1K | ﹤0.01% | 2362 |
|
|
2023
Q4 | $26K | Buy |
2,824
+249
| +10% | +$2.29K | ﹤0.01% | 2535 |
|
|
2023
Q3 | $27K | Hold |
2,575
| – | – | ﹤0.01% | 2516 |
|
|
2023
Q2 | $37K | Sell |
2,575
-659
| -20% | -$9.47K | ﹤0.01% | 2447 |
|
|
2023
Q1 | $23K | Sell |
3,234
-339
| -9% | -$2.41K | ﹤0.01% | 2598 |
|
|
2022
Q4 | $40K | Hold |
3,573
| – | – | ﹤0.01% | 2522 |
|
|
2022
Q3 | $40K | Buy |
3,573
+55
| +2% | +$616 | ﹤0.01% | 2556 |
|
|
2022
Q2 | $30K | Buy |
3,518
+209
| +6% | +$1.78K | ﹤0.01% | 2721 |
|
|
2022
Q1 | $45K | Buy |
+3,309
| New | +$45K | ﹤0.01% | 2535 |
|